Sterling Capital Management’s Upstream Bio UPB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.9K Buy
740
+30
+4% +$196 ﹤0.01% 2962
2026
Q2
$4.91K Sell
710
-384
-35% -$3.22K ﹤0.01% 2622
2026
Q1
$9.8K Sell
1,094
-825
-43% -$14.8K ﹤0.01% 2377
2025
Q4
$52.1K Sell
1,919
-345
-15% -$8.59K ﹤0.01% 1787
2025
Q3
$42.6K Buy
2,264
+1,323
+141% +$20.6K ﹤0.01% 1809
2025
Q2
$10.3K Buy
941
+804
+587% +$7.42K ﹤0.01% 2112
2025
Q1
$838 Sell
137
-112
-45% -$1.07K ﹤0.01% 2871
2024
Q4
$4.09K Buy
+249
New +$5.56K ﹤0.01% 2544

Other funds holding UPB

Sterling Capital Management's UPB Position: Q3 2026 in Review

Sterling Capital Management increased its Upstream Bio (UPB) stake by 4.2% in Q3 2026, buying an estimated $196 and bringing the position to 740 shares worth $3.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2962.

Sterling Capital Management first reported a position in UPB in Q4 2024 and has held it in 8 quarters since. The position peaked at $52.1K in Q4 2025. 135 funds tracked by Wall St. Rank hold UPB as of Q3 2026.

  • Sterling Capital Management held 740 shares of Upstream Bio worth $3.9K as of Q3 2026.
  • Sterling Capital Management bought 30 Upstream Bio shares in Q3 2026, an estimated $196.
  • Upstream Bio made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2962 holding.
  • Sterling Capital Management first reported a position in Upstream Bio in Q4 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Upstream Bio position peaked at $52.1K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Upstream Bio as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.